You are here: Home » PTI Stories » National » News
Business Standard

Vivimed Lab gains 8 pc on successful USFDA inspection

Press Trust of India  |  New Delhi 

of today settled for the day with gains of 8 per cent after the US health regulator completed the inspection of its manufacturing facility in Alathur.

The stock jumped 7.96 per cent and ended the day at Rs 99.70 on BSE. Intra-day the stock had surged 16.29 per cent.



On NSE, of the company went up by 7.72 per cent and settled at Rs 99.80. During the day, the stock had risen 16.99 per cent to touch an intra-day high of Rs 108.40.

The company's 'Finished Dosage Form' manufacturing facility had a favourable outcome post its US Food and Drug Administration (USFDA) inspection. The audit was conducted during the last week of November and concluded on November 28, 2016.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," MD Santosh Varalwar had said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Vivimed Lab gains 8 pc on successful USFDA inspection

Shares of Vivimed Labs today settled for the day with gains of 8 per cent after the US health regulator completed the inspection of its manufacturing facility in Alathur. The stock jumped 7.96 per cent and ended the day at Rs 99.70 on BSE. Intra-day the stock had surged 16.29 per cent. On NSE, shares of the company went up by 7.72 per cent and settled at Rs 99.80. During the day, the stock had risen 16.99 per cent to touch an intra-day high of Rs 108.40. The company's 'Finished Dosage Form' manufacturing facility had a favourable outcome post its US Food and Drug Administration (USFDA) inspection. The audit was conducted during the last week of November and concluded on November 28, 2016. "We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," Vivimed Labs MD Santosh Varalwar had said. of today settled for the day with gains of 8 per cent after the US health regulator completed the inspection of its manufacturing facility in Alathur.

The stock jumped 7.96 per cent and ended the day at Rs 99.70 on BSE. Intra-day the stock had surged 16.29 per cent.

On NSE, of the company went up by 7.72 per cent and settled at Rs 99.80. During the day, the stock had risen 16.99 per cent to touch an intra-day high of Rs 108.40.

The company's 'Finished Dosage Form' manufacturing facility had a favourable outcome post its US Food and Drug Administration (USFDA) inspection. The audit was conducted during the last week of November and concluded on November 28, 2016.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," MD Santosh Varalwar had said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Vivimed Lab gains 8 pc on successful USFDA inspection

of today settled for the day with gains of 8 per cent after the US health regulator completed the inspection of its manufacturing facility in Alathur.

The stock jumped 7.96 per cent and ended the day at Rs 99.70 on BSE. Intra-day the stock had surged 16.29 per cent.

On NSE, of the company went up by 7.72 per cent and settled at Rs 99.80. During the day, the stock had risen 16.99 per cent to touch an intra-day high of Rs 108.40.

The company's 'Finished Dosage Form' manufacturing facility had a favourable outcome post its US Food and Drug Administration (USFDA) inspection. The audit was conducted during the last week of November and concluded on November 28, 2016.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," MD Santosh Varalwar had said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard